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The L1 cell adhesion molecule (CD171) is a multidomain
membrane glycoprotein of the immunoglobulin superfamily.
We evaluated its expression in human acute kidney injury
and assessed its use as a tissue and urinary marker of acute
tubular injury. Using immunohistochemical studies with
antibodies to the extracellular or cytoplasmic domains, we
compared L1 expression in normal kidneys in 24 biopsies
taken from patients with acute tubular necrosis. L1 was
found at the basolateral and the lateral membrane in all
epithelial cells of the collecting duct in the normal kidney
except for intercalated cells. In acute tubular necrosis, L1 lost
its polarized distribution being found in both the basolateral
and apical domains of the collecting duct. Further, it was
induced in thick ascending limb and distal tubule cells.
Apically expressed L1 found only when the cytoplasmic
domain antibody was used in biopsy specimens of patients
with acute tubular necrosis. The levels of urinary L1,
normalized for creatinine, were significantly higher in
all 24 patients with acute tubular necrosis compared to
five patients with prerenal azotemia or to six patients with
other causes of acute kidney injury. Our study shows that
a soluble form of human L1 can be detected in the urine
of patients with acute tubular necrosis and that this may
be a marker of distal nephron injury.
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Acute tubular necrosis (ATN) is the most common cause
of acute kidney injury (AKI), resulting from septic, toxic,
or ischemic insult.1–3 ATN is a potentially reversible process,
but patients frequently die before renal recovery as a result
of comorbid illness and ATN itself.3,4 Morphological studies
of human ATN have shown that all segments, including
proximal tubules, thick ascending limbs (TALs), distal con-
voluted tubules, and collecting ducts (CD), could be injured,
with loss of brush border, loss of cellular polarity, dedifferen-
tiation, apoptosis, and shedding of viable or necrotic
epithelial tubule cells from the basement membrane resulting
in intraluminal obstruction.5–12 During recovery, surviving
dedifferentiated cells spread over the denuded basement
membrane, undergo mitogenesis, and ultimately re-differen-
tiate and re-establish normal epithelial polarity resulting in a
normal functional epithelium.13–15 However, the molecular
events leading to tubular cell death and restoration of tubule
integrity are complex and incompletely understood.1,12 In
particular, data about molecular alterations within the CDs
during ATN remain sparse, due to the limited material
available in human biopsies and to the differences between
human ATN and currently used animal models in which the
most injured segments are proximal tubules.2 Furthermore,
there is an urgent need for biomarkers that could allow
earlier detection of injury, identify the most affected nephron
segments, guide timing of therapy, and screen patients at risk
for renal injury.16,17
The cell adhesion molecules (CAMs) play a key role in
maintenance of tubule integrity by mediating cell–cell and
cell–matrix interactions. Beyond their structural function,
they are implicated in control of cell mitogenesis, differentia-
tion, anchorage dependence, and apoptosis, all features of
the recovering nephron.18–20 One of these CAMs, L1 (CD171)
is a multidomain membrane glycoprotein of the immuno-
globulin superfamily, expressed in neural, hematopoietic, and
epithelial cells, which promotes many cellular activities by
interacting with a group of CAMs, extracellular matrix mole-
cules, and cell-surface receptors.21,22 In addition to being
expressed on the cell surface, L1 can be cleaved and released
in a soluble form into extracellular space.23 The soluble L1
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has been shown to stimulate cell migration and survival.24 L1
cleavage is enhanced under certain pathological conditions.25
In the kidney, L1 is strongly expressed in CDs and connecting
segments on the basolateral membrane of principal cells.26,27
Considering its distribution in the kidney and its multifunc-
tional potential, L1 is a candidate for playing a role in ATN,
especially in CD injury and recovery.
The aim of our study was to evaluate whether L1 expres-
sion is changed in human ATN and to assess its potential
interest as a renal injury marker. We have analyzed L1
expression during ATN in a series of 24 human biopsies from
native and grafted kidney, using multiple dual-immunostain-
ing experiments with markers of differentiation (aquaporins
1, 2, and 3; Tamm–Horsfall protein; epithelial membrane
antigen (EMA)), cell polarity (ZO-1), and proliferation
(Ki-67). Herein, we report that L1 re-distributes to the
apical membrane of CD and is upregulated in TAL during
ATN. Furthermore, the differential analysis of L1 intra- and
extracytoplasmic domains by distinct antibodies in renal
tissue and urine fluid suggests that L1 is cleaved and released
in tubule lumen and that L1 may be a biomarker for distal
segment injury.
RESULTS
Distribution of L1 in kidneys with acute tubular necrosis
Renal biopsies were obtained from patients with diagnosis
of ATN. Their clinical and pathological characteristics are
summarized in Table 1. In comparison with normal kidney
where L1 is expressed on basolateral membranes of principal
cells,26,27 the distribution of L1 was wider in renal biopsies
with ATN, whether in native or grafted kidneys. In addition
to CDs, L1 was expressed at the apical membrane of distinct
tubules (Figure 1a), most of them being TAL labeled
by Tamm–Horsfall protein (Figure 1b). Dual staining with
anti-aquaporin 1 showed that proximal tubules, including
the S3 segments, never expressed L1 (Figure 1a). A fraction
of tubules with L1 apical staining were aquaporin 2 and
3 negative, Tamm–Horsfall negative, but EMA positive
(Figure 1c). Most of them were probably distal convoluted
tubules even though some could be injured TALs with
complete loss of Tamm–Horsfall protein expression.
Morphological injuries of TALs and CDs were observed
both in native and grafted kidneys, with TALs and CDs dis-
ruption and large cast of cell debris filling the lumen
(Figure 2). All cases showed the same alteration of L1 expres-
sion, that is, its upregulation in TAL and its delocalization to
the apical membrane in CD, regardless of the cause. Most
TALs expressing L1 were severely injured with a flattened
epithelium and a dilated lumen (Figure 2a and b). The CDs
that expressed L1 at the apical membrane had flattened
epithelium (Figure 2c and d), whereas CDs with predomi-
nant basolateral L1 expression were mostly with a normal
appearance (Figure 2a and b). Interestingly, detached cells
with a viable appearance were seen within the CD lumen,
aggregating to themselves and expressing L1 on their mem-
branes (Figure 2c and d). We investigated further whether the
L1 apical expression was associated with cell regeneration.
Dual staining with the cell cycle marker Ki-67 showed posi-
tive nuclei within proximal tubules, TAL (data not shown),
and CD, but regardless of L1 expression (Figure 2e).
L1 subcellular localization and cell polarity
The apical delocalization of L1 in CDs raised the question
of a total loss of cell polarity during the pathological process.
Two observations argued against this hypothesis. First, aqua-
porin 2 was normally kept at the apical membrane of prin-
cipal cells in all cases. Similarly, aquaporin 3 was normally
expressed at the basolateral membrane of principal cells
(Figure 2d). Second, we performed an immunostaining of the
ZO-1 protein, a major component of the zonula occludens
junction implicated in the cell polarity control. In normal
CD, ZO-1 immunostaining gave a strong punctate and linear
pattern at the lateral subapical domain (Figure 3b and e).
We did not observe any alteration of this pattern in injured
CD, even when L1 was completely delocalized to the apical
membrane (Figure 3f).
Comparative subcellular localization of L1 intra- and
extracytoplasmic domains
Considering that L1 could be cleaved in these pathological
conditions, we compared L1 immunostaining obtained with
the two different antibodies specific for the cytoplasmic domain
and extracellular Ig-like domain, respectively (Figure 4a).
In normal CD, we observed a strict colocalization of these
antibodies with a basolateral pattern (Figure 4b–d). In most
injured CDs, the extracellular moiety recognized by mono-
clonal antibody (mAb)272 was not detected at the apical
membrane, whereas a strong staining corresponding to the
intracytoplasmic moiety was observed with the polyclonal
antibody (Figure 4e). These observations suggested that the
ectodomain could be released within the tubular lumen.
Detection and quantitation of a soluble released form of L1
in human urine samples
To investigate which molecular forms of L1 are present in the
urine under pathological conditions, we analyzed prospec-
tively the urine fluid of 24 patients with ATN (15 native and
9 grafted kidneys). Clinical characteristics of these patients
are summarized in Table 2. The intra- and extracytoplasmic
domains of the L1 protein were detected by western blot. In
controls and in patients with prerenal azotemia, we observed
no L1 or a faint band at 220 kDa both detected by the mono-
clonal (Figure 5) and the polyclonal antibody (data not
shown), suggesting a low basal release of the complete L1. In
the patients with ATN, a broad band at 140 kDa was detected
by the mAb directed at the ectodomain (Figure 5), whereas
the polyclonal antibody specific for the intracellular domain
failed to detect any protein (data not shown). These data
support our hypothesis of a cleavage of L1 ectodomain in
tubular lumen, during ATN or the following repair steps.
Urine samples from patients with other causes of AKI had low
amount of both complete and soluble forms of L1 (Figure 5).
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Quantitation of L1 in the urine was performed by enzyme-
linked immunosorbent assay (ELISA). Both absolute urinary
human L1 concentration and L1 concentration normalized
for urinary creatinine level were much higher in patients with
ATN than in those with other causes of AKI (Tables 2 and 3).
DISCUSSION
Although ATN is a frequent pathological process, molecular
data are mostly limited to the S3 proximal segment and CD/
TAL have been rarely investigated so far. In previous works,
we have shown that the L1 CAM is strictly restricted to the
basolateral membrane of principal cells of CD and connect-
ing segments in normal kidney.26,27 Herein, we report that L1
expression is severely altered during ATN, with an upregula-
tion in TAL, a loss of the basolateral expression, and an apical
re-distribution in CD. By contrast, L1 is not induced in the
S3 proximal segment. We also show that a cleaved form of
L1 shows up in the urine in patients with ATN but not in
those with prerenal azotemia, and that patients with ATN
had significantly greater urinary L1 level than those with
other causes of AKI.
L1 is involved through homophilic interactions in cell–cell
adhesion,21,22 and the loss of its basolateral expression could
contribute to detachment of CD epithelial cells or back-
leakage of tubular fluid.28 However, other CAM playing a role
in CD cohesion maintenance could partially or completely
compensate this effect. In particular, E-cadherin remained
normally expressed on the basolateral membrane of CD cells
in our series (data not shown), and the cells expressing L1 on
the apical membrane remained cohesive. During ATN,
proximal tubule cells lose their polarity and the integrity of
their tight junctions is disrupted as shown in the post-
ischemic transplanted kidney.28 The Naþ /Kþ -ATPase and
integrins are redistributed to the apical surface in cell
cultures,29 and the actin network is altered in the ischemia–
Table 1 | Clinical and pathological features in ATN patients with renal biopsy
Case Gender
Age
(years)
Creat. at
biopsy
(lmol l1) Kidney
Etiology for
AKI in native
kidney
Etiology for
ESRD before
grafted kidney
AKI to
biopsy
(days)
Time from
graft to biopsy
(days)
Tubular
lesions L1 apical Outcome
B1 M 54 800 Native NSAID 3 +++ ++ FR
B2 F 41 689 Native Rhabdomyolysis 1 ++ ++ FR
B3 M 59 1100 Native Hypovolemia 4 +++ + FR
B4 M 32 600 Native Rhabdomyolysis 4 + ++ FR
B5 M 71 447 Native Cisplatin 6 +++ +++ D
B6 F 82 600 Native Aminosides 10 +++ + PR
B7 F 57 480 Native Hypovolemia 10 +++ + PR
B8 F 56 800 Native Hypovolemia 5 ++ +++ ESRF
B9 F 53 568 Native Hypovolemia 2 +++ ++ FR
B10 F 14 323 Native NSAID 1 ++ ++ FR
B11 M 70 560 Native Hypovolemia 7 ++ + FR
B12 M 19 800 Native Vancomycin 6 +++ +++ PR
B13 M 61 1000 Grafted FSGS 10 +++ + FR
B14 F 38 500 Grafted IgA N 8 +++ +++ FR
B15 M 31 1200 Grafted Polycystic kidney 8 ++ + FR
B16 M 62 250 Grafted Diabetic N 13 +++ ++ FR
B17 M 42 141 Grafted Polycystic kidney 26 ++ ++ FR
B18 F 39 250 Grafted Diabetic N 25 ++ + FR
B19 F 66 600 Grafted FSGS 10 ++ ++ FR
B20 M 64 310 Grafted Undetermined 21 + ++ FR
B21 M 49 264 Grafted Vascular N 28 ++ ++ FR
B22 M 43 400 Grafted MPGN 14 ++ ++ FR
B23 M 15 420 Grafted Membranous N 4 +++ + FR
B24 M 20 400 Grafted Undetermined 15 ++ + FR
AKI, acute kidney injury; ATN, acute tubular necrosis; D, death; ESRD, end-stage renal disease; F, female; FR, full recovery; FSGS, focal segmental glomerulosclerosis; M, male;
MPGN, membranoproliferative glomerulopathy; N, nephropathy; NSAID, non-steroidal anti-inflammatory drugs; PR, partial recovery.
Creat. at biopsy, plasmatic creatinine assessed at biopsy; AKI to biopsy (days), time between acute renal failure diagnosis and biopsy.
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c
Figure 1 | Abnormal expression of L1 in ATN. (a) L1 labeled by
FITC (green) is detected both in CDs (arrows) and at the apical
membrane of other tubules (arrowheads). Proximal tubules
expressing aquaporin 1 labeled by rhodamine do not express L1
(asterisks). (b) Most of the tubules with apical L1 are TALs expressing
Tamm–Horsfall protein labeled by blue Alexa (arrowheads). Note
that L1 is apical in some principal cells of CDs (arrow), colocalizing
with aquaporin 2 labeled by rhodamine. (c) L1 labeled by FITC
(green) and EMA by rhodamine (red) are coexpressed in some
distal tubules (merge, arrow), which are Tamm–Horsfall and
aquaporin 2 and 3 negative. Original magnification  400.
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reperfusion model.30,31 In agreement with previous studies
that failed to detect such a loss of polarity in CD, our data
do not support that L1 apical expression during ATN is
related to a loss of polarity in principal cells.32 In our study,
aquaporins 2 and 3 remained normally expressed on the apical
and basolateral membrane, respectively. Furthermore, we did
not detect any change in the ZO-1 pattern in injured CD.
The dual staining with distinct anti-L1 antibodies recog-
nizing intra- or extracytoplasmic domain gave some insight
into the L1 processing. In nearly all cases, only the intra-
cytoplasmic moiety could be detected on the apical mem-
brane, suggesting that the extracytoplasmic part has been
cleaved and released within the lumen. Because of the
retrospective design of the study, no urine fluid was available
for the investigated renal biopsies. Therefore, we analyzed
24 urine samples from additional patients with an ATN
diagnosis. In normal control samples, the L1 protein was
absent or present in low amount only in a complete form of
220 kDa. By contrast, in patients with ATN, we observed that
the L1 extracellular fragment was significantly detected in
urine samples, whereas the intracellular domain was absent.
These data strongly suggest that L1 is expressed on the apical
membrane, further cleaved, and then released within the
tubule lumen. Similarly, kidney injury molecule-1 is a CAM
expressed at apical membrane, cleaved by a metalloproteinase,
and released in the urine fluid.33 Whether L1 is actually
cleaved within the tubule lumen by metalloproteinase and/or
plasmin remains to be demonstrated. Bonventre and co-
workers proposed that kidney injury molecule-1 could be
involved in tubule restoration by mediating interactions
between viable detached cells and denuded matrix.34 Such a
role could be discussed for L1 in CD and TAL, where L1 may
mediate interaction with laminin-5, which is induced during
ischemic injury and repair.35 In contrast, L1 could exert an
a b
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Figure 2 | Heterogeneous features of tubules expressing L1 in
ATN. (a, b) Adjacent sections of TAL showing damaged epithelium.
(a) Masson’s trichrome staining, arrow indicates partially denuded
TAL tubules with flattened epithelium and casts. (b) L1 labeled
by FITC is detected at the luminal side (arrows) of the severely
injured TAL expressing residual Tamm-Horsfall protein labeled
with rhodamine (asterisk) and mostly at the basolateral membrane
of the epithelium in the CD tubules with nearly normal morphology
(arrowhead). (c, d) Adjacent sections of CD showing damaged
epithelium. (c) Masson’s trichrome staining, CD tubule with flattened
epithelium. (d) CD identified by aquaporin 3 (rhodamine; red)
displays apical L1 (arrows) (FITC; green). Note in the lumen
detached cells expressing L1 and aggregating themselves (asterisk).
(e) Ki-67-positive nuclei are present both in L1-positive (arrow)
or L1-negative (arrowhead) tubules. Original magnification  400.
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Figure 3 | L1 localization and cell polarity. (a–c) Comparison of L1 (FITC; green) and Z0-1 (rhodamine; red) expression pattern in normal
and (d–f) injured CD cells. Note the stable punctate pattern of ZO-1 in subapical domain of principal cells (arrowheads), whether they
are (b) normal or (e) injured. By contrast, L1 is shifted from the basolateral domain in (a) normal cells to the apical domain in (d) injured
cells (arrows). (c, f) Merge. Original magnification  630.
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adverse effect by promoting aggregation of cells within the
lumen and favoring tubule obstruction, as shown in this work.
Our observations strongly suggest that L1 could be a
potential biomarker of distal injury during AKI. Most mole-
cules as yet reported, including kidney injury molecule-1 and
interleukin-18 are biomarkers of S3 proximal segment injury
in animal models and human AKI conditions.36,37 Contrary
to kidney injury molecule-1, which is synthesized in the S3
proximal segment,33,34 the source of proximal tubule
neutrophil gelatinase-associated lipocalin, another early
marker of kidney damage, is likely the glomerular filtrate,38,39
but recent data suggest that urinary neutrophil gelatinase-
associated lipocalin could be the mostly derived from distal
part of the nephron.40 As shown in our work and previous
studies, TAL and CD injury is frequent during ATN but
undetected by biomarkers of proximal tubular injury.5–9
Since L1 induction in ATN is closely related to distal injury,
it could be highly advantageous to include L1 as a distal
biomarker in clinical evaluation. Future studies will investi-
gate the clinical usefulness of urinary L1 assays.
Interestingly, L1 ectodomain was not detected in the urine
of patients with prerenal azotemia. If prerenal azotemia with
poor renal perfusion is prolonged, progressive renal damage
with tubular cell necrosis will develop.1 Thus, prerenal
azotemia and tubular ischemia represent stages in the conti-
nuum of tubular injury. A rapid and differential diagnosis
between prerenal azotemia and ATN would be highly
valuable at the bedside.41 In this context, urinary L1 ecto-
domain excretion might be a new tool to discriminate ATN
from prerenal azotemia. Additional ELISA-based studies of
L1 excretion in large groups of patients are required to define
thresholds of L1 urinary excretion at all stages of AKI from
prerenal azotemia to full-blown ATN and recovery.
Urine samples from patients with other intrinsic causes of
AKI showed only small elevation of urinary L1 protein, which
is in keeping with the lack of extensive tubular cell injury in
those patients. Because there was no overlap of urinary L1
levels between ATN and other groups, we propose that
urinary L1 levels may also be useful to differentiate ATN from
other causes of AKI.
As in most human ATN series, the biopsies studied herein
originated from patients with an unexpected evolution and a
sustained renal failure. Because we cannot eliminate a
selection bias, our observations cannot be extended to all
patients without caution. Furthermore, time-course expres-
sion of L1 cannot be easily studied in human biopsies.
Ig-like FNIII Cyt
mAb272
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Figure 4 | Comparative localization of L1 intra- and extracytoplasmic domains. (a) L1 scheme showing the extracellular part with six
immunoglobulin-like domains (Ig-like) (including one recognized by mAb272) and five fibronectin III-like (FNIII) domains followed by the
transmembrane segment and cytoplasmic fragments (recognized by the goat polyclonal serum). (b–d) Normal CDs are compared with
(e–g) damaged CDs. (b, e) CDs are stained by goat polyclonal antiserum labeled by FITC (green) and (c, f) mAb272 labeled by rhodamine
(red). (d, g) Merge. (d) In normal CD, both antibodies give a basolateral signal. (g) In injured principal cells, the basolateral signal is low
with both antibodies, whereas there is a strong apical membrane (arrow) signal with the anti-cytoplasmic domain antibody contrasting
with no signal for the extracellular fragment. Original magnification  630.
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During the last decades, a considerable interest in AKI has led
to the generation of multiple animal models.42–45 Further
studies on the role of L1 in ATN will target the experimental
models with TAL and CD lesions, that is, the cold ischemic
model or toxic injuries combining salt depletion, non-steroid
anti-inflammatory drugs, and radiocontrast agents.46
In conclusion, our study first describes that expression of
the L1 CAM is altered during ATN, being induced in TAL and
re-distributed at apical membrane in CD, where it is probably
cleaved and released in tubular lumen. As a result, L1
ectodomain was detected in urine samples, suggesting that L1
could be a useful biomarker of distal injury in clinical practice.
MATERIALS AND METHODS
Renal tissues, urine samples, and clinical data
All tissue specimens were collected during the period 1996–2002,
and retrieved from the Department of Pathology, Tenon Hospital,
Paris. Renal biopsies were obtained from patients with a clinico-
pathological diagnosis of ATN, including 12 cases on native kidneys
and 12 cases on grafted kidneys (Table 1). All these patients presen-
ted with an acute renal dysfunction (without rapid improvement
after correction of a possible prerenal cause and a fractional excre-
tion of sodium 42%), and the renal biopsy examination displayed
signs of acute tubular injury (necrosis, loss of brush border,
de-differentiation) and excluded other causes of acute parenchymal
disease (acute interstitial nephritis, glomerulonephritis, vascular renal
disease, or rejection for grafted patients). Control tissues were taken
Table 2 | Clinical features in ATN patients with L1 detected in urine samples
Case Gender
Age
(years)
Creat. at UA
(lmol l1)
Etiology for AKI
in native kidney
Etiology for
ESRD before
grafted kidney
Time from graft
to UA (days) Outcome
Absolute L1
(ng ml1)
Normalized L1
(ng mg1 UCr)
N1 M 86 175 Rhabdomyolysis — FR 1.20 1.32
N2 M 38 250 Rhabdomyolysis — FR 1.45 1.70
N3 F 14 180 Rhabdomyolysis — D 1.30 2.70
N4 M 60 180 Hypovolemia — D 1.50 2.02
N5 M 78 516 Hypovolemia — D 2.25 2.27
N6 M 68 752 Hypovolemia — PR 1.50 2.14
N7 M 76 523 Hypovolemia — PR 1.60 2.46
N8 M 96 572 Septic shock — FR 1.50 2.50
N9 M 46 250 Septic shock — FR 1.50 1.64
N10 M 78 588 Septic shock — FR 1.60 1.70
N11 M 62 242 Cardiac arrest — D 1.40 2.91
N12 F 61 323 Cardiac arrest — FR 1.45 1.81
N13 M 33 1187 Malaria — FR 1.30 2.60
N14 M 69 320 Toxic — FR 1.20 1.33
N15 M 58 248 Toxic — FR 1.25 1.28
G1 F 50 850 — Undetermined 7 FR 1.70 2.29
G2 M 36 530 — Malformative U 12 FR 1.90 2.10
G3 F 44 864 — IgA N 6 FR 2.10 2.12
G4 M 40 732 — MPGN 8 FR 1.90 2.11
G5 H 41 835 — Polycystic kidney 4 FR 2.40 2.18
G6 F 45 478 — Lupus nephritis 11 FR 1.60 1.30
G7 M 68 170 — ANCA vasculitis 12 PR 1.90 2.10
G8 M 62 362 — Diabetic N 2 FR 1.40 1.50
G9 F 58 358 — Hyperoxaluria 8 FR 1.20 1.26
ANCA, antineutrophil cytoplasmic antibodies; AKI, acute kidney injury; ATN, acute tubular necrosis; D, death; ESRD, end-stage renal disease; F, female; FR, full recovery;
M, male; MPGN, membranoproliferative glomerulopathy; N, nephropathy; PR, partial recovery; U, uropathy; UA, urine analysis (L1 western blot); UCr, urinary creatinine
concentration.
Creat at UA, plasmatic creatinine assessed at urine analysis; N, native kidney; G, grafted kidney.
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Figure 5 | Western blot analysis of urine samples with mAb272.
Each lane shows representative L1 patterns identified by western
blot in urine of control and of patients with various causes of
AKI. Note the 220 kDa integral form in control samples and the
appearance of a 140 kDa cleaved form in patients with ATN with
no or trace amount of the integral form.
Table 3 | Comparison of urinary L1 levels in patients with
various causes of AKI
Group
Absolute L1 (ng ml1),
mean±s.d.
Normalized L1 (ng mg1 UCr),
mean±s.d. Pa
ATN
(n=24)
1.59±0.33 1.97±0.49 —
Prerenal
(n=5)
0.14±0.03 0.19±0.08 o0.001
Other AKI
(n=6)
0.30±0.07 0.40±0.09 o0.001
Controls
(n=12)
0.09±0.04 0.07±0.03 o0.001
AKI, acute kidney injury; ANOVA, analysis of variance; ATN, acute tubular necrosis;
UCr, urinary creatinine concentration.
aL1 values were compared between ATN and other groups using ANOVA.
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from the unaffected pole of three kidneys removed for renal cell
carcinoma. After removal, each sample was divided immediately into
two parts, which were fixed in alcohol-formalin-acetic acid (AFA), and
paraffin-embedded or snap-frozen in liquid nitrogen, respectively.
Urine samples were collected prospectively in another group of 35
patients with AKI and 12 controls without renal dysfunction. Patients
with AKI were divided into three subgroups as follows: ATN (fulfilling
the clinical and biological criteria described above (15 in native and 9
in grafted kidneys)), prerenal azotemia (5 patients), and intrinsic AKI
other than ATN (6 patients). The diagnosis of prerenal azotemia
caused by renal hypoperfusion was based on a decreased fractional
excretion of sodium less than 1% and a rapid recovery of glomerular
filtration rate after restoration of appropriate renal perfusion. Patients
with other forms of intrinsic AKI included patients with biopsy-proven
acute interstitial nephritis (n¼ 3) and postinfectious glomerulo-
nephritis (n¼ 3). Urine samples were frozen quickly after collection
and maintained at 80 1C until analysis. All samples and clinical data
were obtained from patients after their informed consent.
Antibodies
The primary mAbs used in this study were mAb272 directed against
the L1 extracellular domain (the generation of the mouse mAb272
and its specificity for L1 have been described previously26);
anti-E-cadherin (1:200; Zymed, Sougth San Francisco, CA, USA);
anti-ZO-1 (1:100; Zymed); anti-EMA (1:200; Dako Cytomation,
Glastrup, Denmark); anti-Ki-67 (1:1000; Dako). The polyclonal
antibodies were goat anti-L1 directed against the cytoplasmic
domain (1:100; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA); rabbit anti-aquaporins 1, 2, and 3 (1:100; Alomone Labs,
Jerusalem, Israel); rabbit anti-Tamm–Horsfall protein (1:2000;
a kind gift from Pierre Verroust, INSERM 538, Paris, France).
Species-specific secondary antibodies conjugated with fluorescein
isothiocyanate (FITC) or rhodamine were obtained from Vector
Laboratories Inc. (Burlingame, CA, USA).
Immunohistochemistry
Sections from frozen biopsies were fixed in acetone for 10 min
at 4 1C, air-dried, and store desiccated at 20 1C until use for
immunohistochemistry. The paraffin-embedded sections were de-
waxed in xylene and rehydrated to phosphate-buffered saline (PBS)
(150 mM NaCl, 10 mM PO4, pH 7.4) through graded alcohols and
microwave heated in 10 mM sodium citrate buffer (pH 6.0) to retrieve
antigen sites. Owing to the limited amount of material, paraffin-
embedded biopsies were used for dual staining using polyclonal anti-
L1 serum and anti-aquaporins 1, 2, or 3, Tamm–Horsfall, EMA, and
anti-Ki-67 antibodies. Frozen biopsies were used for dual staining
using polyclonal anti-L1, anti-ZO-1, and anti-E-cadherin antibodies.
For comparison of L1 immunostaining by the polyclonal
antiserum and mAb272, both frozen and paraffin-embedded
biopsies were used. Sections were quenched with 50 mM NH4Cl
diluted in PBS for 15 min, and washed three times for 5 min in PBS.
Nonspecific binding was inhibited by incubation for 45 min with
10% (v/v) normal fetal calf serum diluted in PBS. Fetal calf serum
(5%, v/v) and Tween-20 (0.05%) in PBS were used for all dilutions
of the primary and secondary antibodies and washing after
incubation. For L1 immunostaining, the polyclonal anti-L1 serum
or mAb272 were added to the sections, left overnight at 4 1C, then
washed and incubated with appropriate fluorescent secondary
antibody for 60 min at room temperature and washed.
Except for Ki-67, dual staining used the same procedure followed by
overnight incubation at 4 1C with the other primary antibody and
revelation by rhodamine-labeled secondary antibody. Sections were
then aqueously mounted and coverslipped. Procedures used for
negative controls included omission of the primary antibody from
the staining protocol and replacement of the primary antibody with
preimmune rabbit or goat serum and mouse IgG in appropriate
concentrations. There were no significant cross-reactions with the
different secondary antibodies during the dual-staining procedures.
For triple staining, the third primary antibody was directly labeled by
Zenon Alexa fluor 647 (Molecular Probes, Eugene, OR, USA) according
to the manufacturer’s instructions. Slides were viewed and digitized
using a confocal laser microscope (Leica TCS SP2; Leica Microsystems
Heidelberg, GmbH, Germany). Images were then imported from photo
compact discs into Adobe Photoshop and labeled.
For double staining with anti-L1 and Ki-67, deparaffinized slides
were incubated overnight with the polyclonal anti-L1 antibody,
washed, and sequentially incubated with rabbit anti-goat biotinyl-
ated antibody (1:400; Dako) and alkaline phosphatase-conjugated
streptavidin (1:250; Dako), and visualized with Fast Red. After
sections were microwaved twice for 5 min at 360 W, they were
processed on an automated instrument (Ventana Nexes; Ventana
Medical Systems, Strasbourg, France) for the Ki-67 immuno-
staining (1:1000) using an indirect biotin–avidin system, the Ventana
Basic DAB detection kit (Ventana Medical Systems, Tucson, AZ,
USA) according to the manufacturer’s instructions. Finally, sections
were dehydrated and mounted in Eukitt for examination with
conventional optical Zeiss microscope.
Immunoblotting
Urine samples were centrifuged at 1000 g to remove cells, casts, and
other debris, and the supernatant was analyzed by western blotting.
Urinary creatinine was measured by using Jaffe’s colorimetric method
(alkaline picrate) to standardize the analysis of urine samples. A 20ml
portion of urine sample containing the same amount of creatinine
was loaded on the gel. Urine samples were separated in 6% sodium
dodecyl sulfate-polyacrylamide gels according to Laemmli, UK and
transferred from gels to polyvinylidene difluoride membranes
(Immobilon-P; Millipore, Strasbourg, France). Membranes were
blocked with super block solution (Pierce Biotechnology, Rockford,
IL, USA) for 1 h at 37 1C and then incubated with mAb272 (1:1000)
or polyclonal anti-L1 (1:500) overnight at 4 1C. Primary antibody
binding to the membranes were visualized by secondary antibodies
goat anti-mouse or donkey anti-goat coupled to horseradish
peroxidase and SuperSignal West Pico chemiluminescence detection
system (Pierce Biotechnology). Signals were recorded by a lumines-
cent image analyzer (Image Reader Chemi-Smart 5000; Vilbert
Lourmat, Marnes la Valle´e, France). For control blots, primary
antibodies were omitted, or isotype-matched murine IgG or
preimmune goat serum were used as the primary antibody.
ELISA
The wells of an ELISA plate were coated overnight at 4 1C with
mAb272 at 20 mg ml1 in PBS. The wells were blocked for 1 h in
SuperBlock TBS (Pierce Biotechnology). One hundred microliters of
either standard recombinant human L1-Fc pure protein (R&D
Systems, Minneapolis, MN, USA) in serial dilutions or urine
samples from control and patients groups were added to the plate in
triplicate, and incubated for 2 h at 37 1C. After four washes with
TBS-T (Tris-buffered saline with 0.1% Tween), goat anti-human L1
extracellular domain antibody was added (R&D Systems), followed
by anti-goat coupled to alkaline phosphatase (Sigma-Aldrich,
St Louis, MO, USA). Color was developed by adding p-nitrophenyl
Kidney International (2008) 73, 751–758 757
Y Allory et al.: L1 and acute tubular necrosis o r i g i n a l a r t i c l e
phosphate liquid substrate system for ELISA (Sigma-Aldrich),
and the reaction was stopped with 3 M NaOH. The absorbance
was measured at 405 nm using a plate reader. The urinary L1
concentration was calculated from a standard curve, and expressed
in absolute terms (ng ml1) or was normalized for the urinary
creatinine concentration (ng mg1 UCr).
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